Determinants for changing the treatment of COPD: a regression analysis from a clinical audit

References

• AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar
• KesslerRPartridgeMRMiravitllesMSymptom variability in patients with severe COPD: a pan-European cross-sectional studyEur Respir J201137226427221115606
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• MiravitllesMWhat was the impact of the Spanish COPD guidelines (GesEPOC) and how can they be improved?Arch Bronconeumol20165211226026686
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLBustamanteVMunozXBarreiroEMoving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine – a critical viewCOPD201411559160224914771
   PubMedGoogle Scholar
• SorianoJBRodriguez-RoisinRChronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentationProc Am Thorac Soc20118436336721816993
   PubMedGoogle Scholar
• PiersonDJClinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resourcesRespir Care200651327728816533418
   PubMed Web of Science ®Google Scholar
• OveringtonJDHuangYCAbramsonMJImplementing clinical guidelines for chronic obstructive pulmonary disease: barriers and solutionsJ Thorac Dis20146111586159625478199
   PubMed Web of Science ®Google Scholar
• DietteGBDalalAAD’SouzaAOLunacsekOENagarSPTreatment patterns of chronic obstructive pulmonary disease in employed adults in the United StatesInt J Chron Obstruct Pulmon Dis20151041542225759574
   PubMed Web of Science ®Google Scholar
• NardiniSCamiciottoliGLociceroSCOPD: maximization of bronchodilationMultidiscip Respir Med2014915025364503
   PubMedGoogle Scholar
• Rodriguez RoisinRArismendiEInhaled corticosteroids withdrawal in severe patients with chronic obstructive pulmonary disease: a wisdom decision?Arch Bronconeumol2015512575825563900
   PubMed Web of Science ®Google Scholar
• WilsonRSethiSAnzuetoAMiravitllesMAntibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary diseaseJ Infect201367649751523973659
   PubMed Web of Science ®Google Scholar
• MartinezFJCalverleyPMGoehringUMBroseMFabbriLMRabeKFEffect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialLancet2015385997185786625684586
   PubMed Web of Science ®Google Scholar
• OsthoffMJenkinsCLeuppiJChronic obstructive pulmonary disease – a treatable diseaseSwiss Med Wkly2013143w1377723592218
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLAbad ArranzMCalero AcunaCClinical audits in outpatient clinics for chronic obstructive pulmonary disease: methodological considerations and workflowPloS One20151011e014185626544556
   PubMed Web of Science ®Google Scholar
• Pozo-RodriguezFAlvarezCJCastro-AcostaAAuditoría clínica de los pacientes hospitalizados por exacerbación de EPOC en España (estudio AUDIPOC): método y organización del trabajo [Clinical audit of patients admitted to hospital in Spain due to exacerbation of COPD (AUDIPOC study): method and organisation]Arch Bronconeumol2010467349357 Spanish20554103
   PubMed Web of Science ®Google Scholar
• HartlSLopez-CamposJLPozo-RodriguezFRisk of death and readmission of hospital-admitted COPD exacerbations: European COPD AuditEur Respir J201647111312126493806
   PubMed Web of Science ®Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• FordESManninoDMWheatonAGTrends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010PloS One201494e9530524751857
   PubMed Web of Science ®Google Scholar
• IzquierdoJLMartinAde LucasPRodriguez-Gonzalez-MoroJMAlmonacidCParavisiniAMisdiagnosis of patients receiving inhaled therapies in primary careInt J Chron Obstruct Pulmon Dis2010524124920714378
   PubMedGoogle Scholar
• FlottorpSAJamtvedtGGibisBMcKeeMUsing Audit and Feedback to Health Professionals to Improve the Quality and Safety of Health CareCopenhagenWorld Health Organization2010
   Google Scholar
• Lopez-CamposJLAsensio-CruzMICastro-AcostaAResults from an audit feedback strategy for chronic obstructive pulmonary disease in-hospital care: a joint analysis from the AUDIPOC and European COPD audit studiesPloS One2014910e11039425333953
   PubMed Web of Science ®Google Scholar
• NardiniSCicchittoGDe BenedettoFAudit on the appropriateness of integrated COPD management: the “ALT-BPCO” projectMultidiscip Respir Med2014914025097757
   PubMedGoogle Scholar
• GlaserDHastingsRHAn introduction to multilevel modeling for anesthesiologistsAnesth Analg2011113487788721680861
   PubMed Web of Science ®Google Scholar
• MerloJMultilevel analytical approaches in social epidemiology: measures of health variation compared with traditional measures of associationJ Epidemiol Community Health200357855055212883048
   PubMed Web of Science ®Google Scholar
• WoodruffPGAgustiARocheNSinghDMartinezFJCurrent concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised managementLancet201538599791789179825943943
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CatalunaJJCalleMSpanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic SurgeryArch Bronconeumol201248724725722561012
   PubMed Web of Science ®Google Scholar
• RossiAGuerrieroMCorradoAGroupOASWithdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)Respir Res2014157725005873
   PubMed Web of Science ®Google Scholar
• Alcazar NavarreteBCasanovaCMiravitllesM“Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease”: a consensus documentArch Bronconeumol201551419319825540900
   PubMed Web of Science ®Google Scholar
• DahlRJadayelDAlagappanVKChenHBanerjiDEfficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON studyInt J Chron Obstruct Pulmon Dis2013850150824159259
   PubMed Web of Science ®Google Scholar
• MiravitllesMVogelmeierCRocheNA review of national guidelines for management of COPD in EuropeEur Respir J201647262563726797035
   PubMed Web of Science ®Google Scholar